![Patrick Hargutt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrick Hargutt
Gründer bei
Stanley Capital Partners LLP
Profil
Patrick Hargutt founded Stanley Capital Partners LLP in 2020, where he is working as Founding Partner from 2020.
Mr. Hargutt also currently works at Stanley Lab, Inc., as Founding Director from 2021, Laboratoire X.O, as Board Director from 2022, and Noden Pharma DAC, as Director from 2020.
Mr. Hargutt also formerly worked at Healthcare AI Acquisition Corp., as Chief Financial Officer & Director and Monarch Alternative Capital (Private Equity), as Vice President from 2018 to 2019.
Mr. Hargutt received his undergraduate degree in 2010 from Technische Universität München.
Aktive Positionen von Patrick Hargutt
| Unternehmen | Position | Beginn |
|---|---|---|
Stanley Capital Partners LLP
 Stanley Capital Partners LLP Investment ManagersFinance Stanley Capital invests in middle market companies located in the United States and Europe with EBITDA ranging from USD25 million - USD150 million with an enterprise values of USD250 million - USD2.5 billion. The firm targets companies operating in the fields of healthcare and technology. It provides financing for growth stage capital requirements. | Gründer | 01.01.2020 |
Noden Pharma DAC
 Noden Pharma DAC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Direktor/Vorstandsmitglied | 01.09.2020 |
Laboratoire X.O
 Laboratoire X.O Pharmaceuticals: MajorHealth Technology Manufactures and sells medical devices & medicines | Direktor/Vorstandsmitglied | 01.09.2022 |
Stanley Lab, Inc.
 Stanley Lab, Inc. Drugstore ChainsRetail Trade Operates as a pharmacy | Direktor/Vorstandsmitglied | 01.03.2021 |
Ehemalige bekannte Positionen von Patrick Hargutt
| Unternehmen | Position | Ende |
|---|---|---|
| HEALTHCARE AI ACQUISITION CORP. | Finanzdirektor/CFO | 12.06.2023 |
Monarch Alternative Capital (Private Equity)
 Monarch Alternative Capital (Private Equity) Investment ManagersFinance Monarch Alternative Capital seeks investment opportunities in companies located in the US. The firm targets companies operating in the fields of broad range of sectors. The firm provides financing in the form of debt of distressed and bankrupt companies. | Private Equity Investor | 31.10.2019 |
Ausbildung von Patrick Hargutt
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
9
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Technische Universität München
 Technische Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanley Lab, Inc.
Stanley Lab, Inc. Drugstore ChainsRetail Trade Operates as a pharmacy | Retail Trade |
Laboratoire X.O
Laboratoire X.O Pharmaceuticals: MajorHealth Technology Manufactures and sells medical devices & medicines | Health Technology |
Monarch Alternative Capital (Private Equity)
Monarch Alternative Capital (Private Equity) Investment ManagersFinance Monarch Alternative Capital seeks investment opportunities in companies located in the US. The firm targets companies operating in the fields of broad range of sectors. The firm provides financing in the form of debt of distressed and bankrupt companies. | Finance |
Noden Pharma DAC
Noden Pharma DAC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Stanley Capital Partners LLP
Stanley Capital Partners LLP Investment ManagersFinance Stanley Capital invests in middle market companies located in the United States and Europe with EBITDA ranging from USD25 million - USD150 million with an enterprise values of USD250 million - USD2.5 billion. The firm targets companies operating in the fields of healthcare and technology. It provides financing for growth stage capital requirements. | Finance |
Healthcare AI Acquisition Corp.
 Healthcare AI Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
